Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;76(8):3628-31.
doi: 10.1128/IAI.00471-08. Epub 2008 Jun 2.

Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity

Affiliations

Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity

Sumana Chakravarty et al. Infect Immun. 2008 Aug.

Abstract

The protective immune response against liver stages of the malaria parasite critically requires CD8(+) T cells. Although the nature of the effector mechanism utilized by these cells to repress parasite development remains unclear, a critical role for gamma interferon (IFN-gamma) has been widely assumed based on circumstantial evidence. However, the requirement for CD8(+) T-cell-mediated IFN-gamma production in protective immunity to this pathogen has not been directly tested. In this report, we use an adoptive transfer strategy with circumsporozoite (CS) protein-specific transgenic T cells to examine the role of CD8(+) T-cell-derived IFN-gamma production in Plasmodium yoelii-infected mice. We show that despite a marginal reduction in the expansion of naive IFN-gamma-deficient CS-specific transgenic T cells, their antiparasite activity remains intact. Further, adoptively transferred IFN-gamma-deficient CD8(+) T cells were as efficient as their wild-type counterparts in limiting parasite growth in naive mice. Taken together, these studies demonstrate that IFN-gamma secretion by CS-specific CD8(+) T cells is not essential to protect mice against live sporozoite challenge.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
(a) BALB/c mice received TCR-Tg cells obtained from WT or IFNγKO transgenic mice and were immunized with 2 × 106 vaccinia virus. Eight days later, the number of tetramer+CD8+ cells was determined by FACS analysis and is plotted as a proportion of total CD8+ cells within splenocytes and hepatic lymphocyte populations. (b) IL-2-secreting cells within the same populations were identified by ELISPOT assay. Histograms represent means ± the standard errors of the mean (n = 4).
FIG. 2.
FIG. 2.
(a) BALB/c mice received TCR-Tg CD8+ T cells isolated from WT or IFNγKO mice and were immunized with 2 × 106 PFU VV-CS. Eight days later, mice were challenged with 3.5 × 104 P. yoelii sporozoites and parasite-specific rRNA levels in the liver determined by quantitative RT-PCR. (b) Mice received WT or IFNγKO TCR-Tg CD8+ T cells and were immunized as described for panel a. Eight days later, 2 × 106 purified TCR-Tg CD8+ spleen cells were recovered and retransferred into secondary naive BALB/c hosts that were subsequently challenged with 3.5 × 104 P. yoelii sporozoites. The parasite load in the liver was evaluated as for panel a. Each bar represents a single mouse. A Student t test was used to evaluate statistical significance.

References

    1. Bruna-Romero, O., J. C. Hafalla, G. Gonzalez-Aseguinolaza, G. Sano, M. Tsuji, and F. Zavala. 2001. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int. J. Parasitol. 311499-1502. - PubMed
    1. Carvalho, L. H., J. C. Hafalla, and F. Zavala. 2001. ELISPOT assay to measure antigen-specific murine CD8+ T-cell responses. J. Immunol. Methods 252207-218. - PubMed
    1. Chakravarty, S., I. A. Cockburn, S. Kuk, M. G. Overstreet, J. B. Sacci, and F. Zavala. 2007. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 131035-1041. - PubMed
    1. Del Giudice, G., D. Grillot, L. Renia, I. Muller, G. Corradin, J. A. Louis, D. Mazier, and P. H. Lambert. 1990. Peptide-primed CD4+ cells and malaria sporozoites. Immunol. Lett. 2559-63. - PubMed
    1. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 1651453-1462. - PubMed

Publication types

Substances